New study:Moderna effective against Delta variant

[Thaiger]

A new lab study shows that the Covid-19 vaccine developed by Moderna is reasonably effective against the growing Delta variant first identified in India. The study found that the vaccine was only slightly less effective against the newer strain than it is against the original Covid-19 virus. The study tested blood serum from 8 subjects who had finished their second Moderna vaccine one week earlier. Moderna stated that the antibodies produced by their vaccine has been effective against all the prevalent variants of note so far, but not quite as powerfully as it is against the original Covid-19 virus. The […]

The post New study:Moderna effective against Delta variant appeared first on Thaiger News.

Read the full story

[Poolie]

Marvellous.

 

When is it available? Oh, next year..................How much is it? Oh, a months salary for an average Thai..................

 

Nice going America.

[TJM]

It seems that the Janssen vaccine from Johnson & Johnson is disappearing in the sunset.  Any idea why?

[robsamui]

6 hours ago, Slugger said:

Marvellous.

When is it available? Oh, next year..................How much is it? Oh, a months salary for an average Thai..................

Nice going America.

All the private hospitals are now taking bookings for Moderna - Priced at 3,400 baht for 2 jabs. Not exactly a month's wages . . . . 

[JamesE]

"Lab study" Sinovac, Sinopharm, and Sputnik V were all released based on lab studies.

[JamesE]

4 hours ago, TJM said:

It seems that the Janssen vaccine from Johnson & Johnson is disappearing in the sunset.  Any idea why?

J&J went into decline in the US when its manufacturing contractor screwed the pooch and produced tens of millions of contaminated doses. By the time they got it straightened out the public sentiment ran the gamut from "No, thanks" to "Are you nuts?" It's still available in the US but mostly targeting vaccine tourists that don't want to wait for both doses of the mRNA shots. Overseas, the long shelf-life market in the developing world where -80C refrigeration isn't available has been mostly filled by AZ. J&J will probably factor into the US/UK/EU vaccine diplomacy efforts.